Profil Penggunaan Antibiotik pada Pasien Klinik Anak di Rumah Sakit MM Indramayu Periode Januari-Maret 2021
DOI:
https://doi.org/10.46799/jhs.v2i11.338Keywords:
prescription;, pediatric;, antibiotic;, MM Indramayu HospitalAbstract
Drugs are substances or combinations of substances, including biological products, which are used to influence or investigate physiological systems. Antibiotics are chemical substances produced by microorganisms that have the ability in aqueous solutions to inhibit the growth or kill microorganisms. This study uses non-experimental methods. The data collection was carried out retrospectively and presented in the form of a table. In this study, in the form of prescriptions for outpatient pediatric patients who used antibiotics at the MM Indramayu Hospital in the period January to March 2021, totaling 257 prescriptions. Based on data taken from outpatient pediatric patient prescriptions based on inclusion criteria. Patient criteria are patients who use antibiotics aged 0-11 years. The criteria for antibiotics included in the study were Rifampicin, Isoniazid, Pyrazinamide, Metronidazole, Cefadroxil, Cotrimoxazol, Cefixim. The strength of the antibiotics used are 100mg-450mg, 226mg, 70mg-300mg, 200mg-500mg, 30 mg, 100 mg, 125mg, 250mg, 500mg, 240mg, 125mg. The rules for using antibiotics are 1 x 1 powder, 2 x 1 ml, 2 x 1 cth, 2 x 1 tablet, 3 x 1 cth, 3 x 1 tablet. The dosage form of antibiotics used is powder, syrup and tablets. The results obtained include: the use of the most types of antibiotics, which is Rifampicin and Isoniazid antibiotics as many as 88 prescriptions (34.24%), the highest dosage strength is indicated by the use of Isoniazid strength 70mg-150 mg as many as 57 prescriptions (22.17%), the use of based on the rules of use, namely once a day, one dosage of pulveres rifampicin 450 mg by 88 prescriptions (34.24%), and the most antibiotic dosage forms used were pulveres/puyer preparations with 206 prescriptions (80.15%)
Published
Issue
Section
License
Copyright (c) 2021 Siti Masripah, Meiti Rosmiati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.